Sarepta Therapeutics Inc (SRPT) — Capital Reinvestment Ratio
Latest as of December 2025:
0.04x
Sarepta Therapeutics Inc (SRPT) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($131.21 Million) in capital expenditures ($5.83 Million). See how much free cash does Sarepta Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$131.21 Million
USD
Capital Expenditures
$5.83 Million
USD
Data as of
Dec 2025
Most recent filing
Sarepta Therapeutics Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Sarepta Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Sarepta Therapeutics Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Sarepta Therapeutics Inc from 2020 to 2020. For live market cap and broader valuation context, see market cap of Sarepta Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.76x | $107.47 Million | $82.20 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow